ÂÜÀòÂÒÂ×

William Glauser is an experienced executive in the life sciences sector, currently serving as the Senior Vice President of Business Strategy at XtalPi Inc. since February 2020, where contributions include raising over $700 million in funding leading to a successful IPO and developing business strategies for drug discovery services. As the Chief Strategy Officer and co-founder of Ibis Therapeutics, William has driven major collaborations and platform commercialization efforts in precision medicine. Previous roles include Senior Partner at IOI Partners LLC and Senior Vice President of Commercial Operations at Seven Bridges, where strategic initiatives enhanced market penetration and service offerings. Early career experience includes a tenure as Vice President of Business Development at Schrödinger, significantly impacting the launch of simulation software for pharmaceutical applications. William Glauser holds advanced degrees in physical chemistry and business administration, supporting a career dedicated to innovation in biopharma and healthcare.